Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle

Obesity develops when caloric intake exceeds metabolic needs. promoting energy expenditure represents an attractive approach in the prevention of this fast-spreading epidemic. here,we report a novel pharmacological strategy in which a natural compound,narciclasine (ncls),attenuates diet-induced obesity (dio) in mice by promoting energy expenditure. moreover,ncls promotes fat clearance from peripheral metabolic tissues,improves blood metabolic parameters in dio mice,and protects these mice from the loss of voluntary physical activity. further investigation suggested that ncls achieves these beneficial effects by promoting a shift from glycolytic to oxidative muscle fibers in the dio mice thereby enhancing mitochondrial respiration and fatty acid oxidation (fao) in the skeletal muscle. moreover,ncls strongly activates ampk signaling specifically in the skeletal muscle. the beneficial effects of ncls treatment in fat clearance and ampk activation were faithfully reproduced in vitro in cultured murine and human primary myotubes. mechanistically,ncls increases cellular camp concentration and adp/atp ratio,which further lead to the activation of ampk signaling. blocking ampk signaling through a specific inhibitor significantly reduces fao in myotubes. finally,ncls also enhances mitochondrial membrane potential and reduces the formation of reactive oxygen species in cultured myotubes. © 2017 julien et al.